Abstract:Introduction: Epidemiological modeling is widely used to offer insights into the COVID-19 pandemic situation in Asia. We reviewed published computational (mathematical/simulation) models conducted in Asia that assessed impacts of pharmacological and non-pharmacological interventions against COVID-19 and their implications for vaccination strategy. Methods: A search of the PubMed database for peer-reviewed, published, and accessible articles in English was performed up to November 2022 to capture studies in Asian populations based on computational modeling of outcomes in the COVID-19 pandemic. Extracted data included model type (mechanistic compartmental/agent-based, statistical, both), intervention type (pharmacological, non-pharmacological), and procedures for parameterizing age. Findings are summarized with descriptive statistics and discussed in terms of the evolving COVID-19 situation. Results: The literature search identified 378 results, of which 59 met criteria for data extraction. China, Japan, and South Korea accounted for approximately half of studies, with fewer from South and South-East Asia. Mechanistic models were most common, either compartmental (61.0%), agent-based (1.7%), or combination (18.6%) models. Statistical modeling was applied less frequently (11.9%). Pharmacological interventions were examined in 59.3% of studies, and most considered vaccination, except one study of an antiviral treatment. Non-pharmacological interventions were also considered in 84.7% of studies. Infection, hospitalization, and mortality were outcomes in 91.5%, 30.5%, and 30.5% of studies, respectively. Approximately a third of studies accounted for age, including 10 that also examined mortality. Four of these studies emphasized benefits in terms of mortality from prioritizing older adults for vaccination under conditions of a limited supply; however, one study noted potential benefits to infection rates from early vaccination of younger adults. Few studies (5.1%) considered the impact of vaccination among children. Conclusion: Early in the COVID-19 pandemic, non-pharmacological interventions helped to mitigate the health burden of COVID-19; however, modeling indicates that high population coverage of effective vaccines will complement and reduce reliance on such interventions. Thus, increasing and maintaining immunity levels in populations through regular booster shots, particularly among at-risk and vulnerable groups, including older adults, might help to protect public health. Future modeling efforts should consider new vaccines and alternative therapies alongside an evolving virus in populations with varied vaccination histories.

How simulation modelling can help reduce the impact of COVID-19

Computational Simulation Is a Vital Resource for Navigating the COVID-19 Pandemic

Role of modelling in COVID-19 policy development

Using simulation modelling and systems science to help contain COVID‐19: A systematic review

How does policy modelling work in practice? A global analysis on the use of modelling in Covid-19 decision-making

The Application of Simulation Methods During the COVID-19 Pandemic: A Scoping Review.

COVID-19 mitigation strategies and overview on results from relevant studies in Europe

Data-driven Simulation and Optimization for Covid-19 Exit Strategies

Analysing the combined health, social and economic impacts of the corovanvirus pandemic using agent-based social simulation

COVID-19: Development of a Robust Mathematical Model and Simulation Package with Consideration for Ageing Population and Time Delay for Control Action and Resusceptibility

COVID-19 Modeling: A Review

Modelling transmission and control of the COVID-19 pandemic in Australia

Handling the COVID-19 Crisis: Toward an Agile Model-Based Systems Approach

An Evaluation of Mathematical Models for the Outbreak of COVID-19

Simulation and forecasting models of COVID-19 taking into account spatio-temporal dynamic characteristics: A review

Modeling the Spread of COVID-19 in University Communities

Simulation-Based Inference for Global Health Decisions

Canada's provincial COVID-19 pandemic modelling efforts: A review of mathematical models and their impacts on the responses

Harnessing Social Media in the Modelling of Pandemics—Challenges and Opportunities

Multi-scale simulation of COVID-19 epidemics

Impact of vaccination and non-pharmacological interventions on COVID-19: a review of simulation modeling studies in Asia